Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.

To improve its immunogenicity for children and adults and to make it suitable for routine immunization of infants against typhoid fever, the capsular polysaccharide of Salmonella typhi (Vi) was bound to the B subunit of the heat-labile toxin (LT-B) of Escherichia coli or the recombinant exoprotein A...

Full description

Saved in:

Bibliographic Details
Published in:	Infect Immun
Main Authors:	Szu, S C, Taylor, D N, Trofa, A C, Clements, J D, Shiloach, J, Sadoff, J C, Bryla, D A, Robbins, J B
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 1994
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303128/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7927707/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.62.10.4440-4444.1994
Tags:	Add Tag No Tags, Be the first to tag this record!

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.

Similar Items